Secondary relevance to vitamin D This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.
This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.
Why this paper is included
Supporting source evidence:
Preoperative demographic and clinical characteristics according to whether osteoporosis was primary or glucocorticoid-inducedTotalPrimaryGIOPp-valueCases, n15913227: Age at time of surgery (years)75.6 ± 6.776.6 ± 6.471.0 ± 6.10.001Sex (male)136 (85.5%)111 (84.1%)25 (92.6%)0.37BMI22.3 ± 5.122.4 ± 4.722.3 ± 6.40.92Smoking history (yes/no)20 (12.6%)19 (14.4%)1 (3.7%)0.20Number of previous vertebral fracture0.5 ± 0.90.4 ± 0.90.7 ± 1.20.20Number of new vertebral fracture1.1 ± 0.21.1 ± 0.21.1 ± 0.30.79Time from injury to surgery (days)173 ± 240169 ± 251192 ± 1840.65BMD (YAM%)71.0 ± 16.170.4 ± 14.573.5 ± 16.40.55Preoperative use of osteoporosis medication71 (44.7%)49 (37.1%)22 (81.5%)< 0.001 BP55 (34.6%)41 (31.1%)14 (51.9%)0.047 Vit D14 (8.8%)7 (5.3%)7 (25.9%)0.003 TP7 (4.4%)4 (3.0%)3 (11.1%)0.10Number of fixed level3.1 ± 0.83.1 ± 0.83.0 ± 0.90.53Preoperative JOA score4.2 ± 3.44.3 ± 3.33.4 ± 3.90.27Preoperative VAS (back pain)71.5 ± 24.470.7 ± 24.375.3 ± 24.90.39Preoperative VAS (leg pain or numbness)55.0 ± 31.755.0 ± 31.954.7 ± 31.50.696GIOP glucocorticoid-induced osteoporosis, BMI body mass index, BMD bone mineral density, YAM young adult mean, BP bisphosphonate, Vit D vitamin D, TP teriparatide, JOA Japan Orthopaedic Association, VAS visual analogue scale
Source: Results. View original paper
Relevance classification does not establish study quality, causation or editorial approval.
Study design Cohort study.
Cohort study
Examines exposures and outcomes over time within a defined group.
Meta-analysis unclear · Blinding unclear / not reported · Human research reported
How this paper was classified
Automatic source-based classification; awaiting editorial verification. This is not a quality score.
The need for informed consent was waived by the ethics committees because this retrospective cohort study involved existing data and records at the time of investigation, and did not retain personal identifiers in the collected information.
Source: Methods.
The patients were followed for average of 3.9 years.
Source: Methods.
What the study types mean
- Systematic review
- Uses explicit methods to identify, assess and summarise research on a defined question.
- Scoping review
- Maps the extent and characteristics of research on a topic.
- Narrative review
- Discusses existing research; systematic-review methods have not been established by this classification.
- Review / evidence synthesis
- Reviews existing research; the exact review methods need further assessment.
- Randomised controlled trial
- Assigns participants or groups to comparison interventions by chance.
- Non-randomised intervention study
- Examines an intervention without random allocation.
- Cohort study
- Examines exposures and outcomes over time within a defined group.
- Case-control study
- Compares people with an outcome against people without it, examining exposures.
- Cross-sectional study
- Examines a population at a particular point in time.
- Observational study
- Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
- Case report
- Describes an individual case.
- Case series
- Describes a group of individual cases.
- Secondary analysis
- Analyses existing study data; this paper is not automatically another independent trial.
- Laboratory study
- Investigates biological processes in a laboratory setting.
- Qualitative study
- Examines experiences or meanings using qualitative methods.
- Genetic instrumental-variable study
- Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
- Study protocol
- Describes planned methods and is not evidence that the planned study has reported results.
- Multiple reported designs
- More than one design is explicitly reported; examine the supporting methods.
- Study design awaiting verification
- The available source does not establish a sufficiently clear study design.
Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.
Abstracts
Effect of bisphosphonates or teriparatide on mechanical complications after posterior instrumented fusion for osteoporotic vertebral fracture: a multi-center retrospective study
Cohort study · BMC Musculoskeletal Disorders · 2020
Original publication title
Effect of bisphosphonates or teriparatide on mechanical complications after posterior instrumented fusion for osteoporotic vertebral fracture: a multi-center retrospective study
© The Author(s) 2020
Original publication · Publisher record · CC BY 4.0 · CC0
Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.
At a glance
Abstract: What background does the paper provide?
The optimal treatment of osteoporosis after reconstruction surgery for osteoporotic vertebral fractures (OVF) remains unclear. In this multicentre retrospective study, we investigated the effects of typically used agents for osteoporosis, namely, bisphosphonates (BP) and teriparatide (TP), on surgical results in patients with osteoporotic vertebral fractures.
Source: BackgroundAbstract: What methods does the paper describe?
Retrospectively registered data were collected from 27 universities and affiliated hospitals in Japan. We compared the effects of BP vs TP on postoperative mechanical complication rates, implant-related reoperation rates, and clinical outcomes in patients who underwent posterior instrumented fusion for OVF. Data were analysed according to whether the osteoporosis was primary or glucocorticoid-induced.
Source: MethodsAbstract: Results
A total of 159 patients who underwent posterior instrumented fusion for OVF were included. The overall mechanical complication rate was significantly lower in the TP group than in the BP group (BP vs TP: 73.1% vs 58.2%, p = 0.045). The screw backout rate was significantly lower and the rates of new vertebral fractures and pseudoarthrosis tended to be lower in the TP group than in the BP group. However, there were no significant differences in lumbar functional scores and visual analogue scale pain scores or in implant-related reoperation rates between the two groups.
The incidence of pseudoarthrosis was significantly higher in patients with glucocorticoid-induced osteoporosis (GIOP) than in those with primary osteoporosis; however, the pseudoarthrosis rate was reduced by using TP. The use of TP also tended to reduce the overall mechanical complication rate in both primary osteoporosis and GIOP.
Source: ResultsAbstract: Conclusions
The overall mechanical complication rate was lower in patients who received TP than in those who received a BP postoperatively, regardless of type of osteoporosis. The incidence of pseudoarthrosis was significantly higher in patients with GIOP, but the use of TP reduced the rate of pseudoarthrosis in GIOP patients. The use of TP was effective to reduce postoperative complications for OVF patients treated with posterior fusion.
Source: ConclusionsAuthors’ abstract
Background
The optimal treatment of osteoporosis after reconstruction surgery for osteoporotic vertebral fractures (OVF) remains unclear. In this multicentre retrospective study, we investigated the effects of typically used agents for osteoporosis, namely, bisphosphonates (BP) and teriparatide (TP), on surgical results in patients with osteoporotic vertebral fractures.
Methods
Retrospectively registered data were collected from 27 universities and affiliated hospitals in Japan. We compared the effects of BP vs TP on postoperative mechanical complication rates, implant-related reoperation rates, and clinical outcomes in patients who underwent posterior instrumented fusion for OVF. Data were analysed according to whether the osteoporosis was primary or glucocorticoid-induced.
Results
A total of 159 patients who underwent posterior instrumented fusion for OVF were included. The overall mechanical complication rate was significantly lower in the TP group than in the BP group (BP vs TP: 73.1% vs 58.2%, p = 0.045). The screw backout rate was significantly lower and the rates of new vertebral fractures and pseudoarthrosis tended to be lower in the TP group than in the BP group. However, there were no significant differences in lumbar functional scores and visual analogue scale pain scores or in implant-related reoperation rates between the two groups.
The incidence of pseudoarthrosis was significantly higher in patients with glucocorticoid-induced osteoporosis (GIOP) than in those with primary osteoporosis; however, the pseudoarthrosis rate was reduced by using TP. The use of TP also tended to reduce the overall mechanical complication rate in both primary osteoporosis and GIOP.
Conclusions
The overall mechanical complication rate was lower in patients who received TP than in those who received a BP postoperatively, regardless of type of osteoporosis. The incidence of pseudoarthrosis was significantly higher in patients with GIOP, but the use of TP reduced the rate of pseudoarthrosis in GIOP patients. The use of TP was effective to reduce postoperative complications for OVF patients treated with posterior fusion.
Publication and source details
Original title: Effect of bisphosphonates or teriparatide on mechanical complications after posterior instrumented fusion for osteoporotic vertebral fracture: a multi-center retrospective study
Atsuyuki Kawabata; Toshitaka Yoshii; Takashi Hirai; Shuta Ushio; Takashi Kaito; Tomoya Yamashita; Hiroyasu Fujiwara; Yukitaka Nagamoto; Yuji Matsuoka; Hidekazu Suzuki; Hirosuke Nishimura; Hidetomi Terai; Koji Tamai; Atsushi Tagami; Syuta Yamada; Shinji Adachi; Kei Watanabe; Keiichi Katsumi; Masayuki Ohashi; Yohei Shibuya; Katsumi Harimaya; Kenichi Kawaguchi; Nobuhiko Yokoyama; Hidekazu Oishi; Toshiro Doi; Atsushi Kimura; Hirokazu Inoue; Gen Inoue; Masayuki Miyagi; Wataru Saito; Atsushi Nakano; Daisuke Sakai; Tadashi Nukaga; Shota Ikegami; Masayuki Shimizu; Toshimasa Futatsugi; Seiji Ohtori; Takeo Furuya; Sumihisa Orita; Shiro Imagama; Kei Ando; Kazuyoshi Kobayashi; Katsuhito Kiyasu; Hideki Murakami; Katsuhito Yoshioka; Shoji Seki; Michio Hongo; Kenichiro Kakutani; Takashi Yurube; Yasuchika Aoki; Masashi Oshima; Masahiko Takahata; Akira Iwata; Hirooki Endo; Tetsuya Abe; Toshinori Tsukanishi; Kazuyoshi Nakanishi; Kota Watanabe; Tomohiro Hikata; Satoshi Suzuki; Norihiro Isogai; Eijiro Okada; Haruki Funao; Seiji Ueda; Yuta Shiono; Kenya Nojiri; Naobumi Hosogane; Ken Ishii
BMC Musculoskeletal Disorders · 2020
© The Author(s) 2020https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.Repository JATS snapshot; version as supplied
Source retrieved: 2026-11-12T17:33:53.091780+00:00
DOI: 10.1186/s12891-020-03452-6 · PMC7331246